SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-023895
Filing Date
2019-05-06
Accepted
2019-05-06 16:06:17
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv519981_10q.htm 10-Q 320879
2 EXHIBIT 31.1 tv519981_ex31-1.htm EX-31.1 9839
3 EXHIBIT 31.2 tv519981_ex31-2.htm EX-31.2 9483
4 EXHIBIT 32.1 tv519981_ex32-1.htm EX-32.1 4220
5 EXHIBIT 32.2 tv519981_ex32-2.htm EX-32.2 4306
  Complete submission text file 0001144204-19-023895.txt   2077277

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20190331.xml EX-101.INS 346482
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20190331.xsd EX-101.SCH 25810
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20190331_cal.xml EX-101.CAL 29776
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20190331_def.xml EX-101.DEF 132643
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20190331_lab.xml EX-101.LAB 177801
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20190331_pre.xml EX-101.PRE 161118
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 19799340
SIC: 2836 Biological Products, (No Diagnostic Substances)